Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001700389-17-000002
Filing Date
2017-05-26
Accepted
2017-05-26 11:15:27
Documents
1
Effectiveness Date
2017-05-26
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9376
  Complete submission text file 0001700389-17-000002.txt   10469
Mailing Address 25 SCIENCE PARK, SUITE 2D 150 MUNSON ST. NEW HAVEN CT 06511
Business Address 25 SCIENCE PARK, SUITE 2D 150 MUNSON ST. NEW HAVEN CT 06511 203-691-6332
Kleo Pharmaceuticals, Inc. (Filer) CIK: 0001700389 (see all company filings)

EIN.: 475508437 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-287320 | Film No.: 17872429